Pfizer CEO warns German investment at risk over drug pricing policies
10/06/2026 12:16
Pfizer CEO warns German investment at risk over drug pricing policies LONDON/FRANKFURT, June 10 (Reuters) - Pfizer PFE.N CEO Albert Bourla said in a letter to German Chancellor Friedrich Merz that the drugmaker is reviewing the timing and scope of planned investments in the country, citing the government's policy proposals that would lower drug prices.
The letter, dated June 9 and seen by Reuters on Wednesday, was first reported by German business newspaper Handelsblatt.
(Reporting by Maggie Fick and Bhanvi Satija in London, and Patricia Weiss in Frankfurt; Editing by Andrew Heavens)
((maggie.fick@thomsonreuters.com; +44 7890 916706;))
Recent news on Pfizer
See all newsU.S. STOCKS ON THE MOVE-Chip stocks, Unicycive, Roblox
U.S. STOCKS ON THE MOVE-AMD, Roblox, Olin
Eli Lilly, Pfizer slip after US House panel probing China clinical trials
US House committee opens investigation into Merck, AbbVie China drug trials (updated)
Brief: U.S. House Committee Sends Letters To Pfizer, Eli Lilly & Bristol Myers Squibb Probing China Drug Trials